You are here

Tivdak

Exelixis drops tissue factor-targeting ADC after deciding it's no match for Tivdak

Fierce Biotech

Wed, 08/7/24 - 11:19 am

antibody-drug conjugate

FDA grants full approval for Pfizer's cervical cancer drug

Reuters

Mon, 04/29/24 - 11:01 pm

cervical cancer

Genmab and Seagen’s TIVDAK trial meets primary endpoint

Clinical Trials Arena

Tue, 09/5/23 - 11:24 am

clinical trials

cervical cancer

Seagen's (SGEN) Cancer Drugs Aid Growth, Stiff Rivalry a Woe

Yahoo/Zacks.com

Fri, 08/12/22 - 10:12 am

FDA hands accelerated nod to Seagen, Genmab's solo ADC in cervical cancer, but combo studies look even more promising

Endpoints

Mon, 09/20/21 - 11:01 pm

accelerated approval

cervical cancer